GGrantIndex
Sort

78,016 grants matching breast cancer

Circulating Vitamin D Levels and Risk of Breast and Colorectal Cancer: a Pooled A

$457,057
Stephanie A Smith-Warner · Harvard School Of Public Health · R01 · FY2011 · CA

Identifying intercellular circuits driving cell phenotypes within a niche

$457,024
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment

$457,013
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2011 · CA

FOUR-CORNERS BREAST CANCER STUDY

$457,011
University Of Colorado Denver · R01 · FY2001 · CA

Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy

$457,001
Anand T.n. Kumar · Massachusetts Eye And Ear Infirmary · R01 · FY2025 · CA

Animal and Biostatics Core

$456,941
Valter D. Longo · University Of Southern California · P01 · FY2012 · AG

Micro-tumor detection by quantifying tumor-induced vascular abnormalities (PQ-13)

$456,910
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA

TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients

$456,895
Sanchita Bhatnagar · University Of California At Davis · R01 · FY2024 · CA

Clinical development of 18F PET tracer for imaging VEGF receptors

$456,892
Joseph M Backer · Sibtech, Inc. · R44 · FY2016 · CA

Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer

$456,888
Brett Stewart Carver · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA

CDC7 kinase in normal and cancer cells: potential implications for cancer treatment

$456,860
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2022 · CA

CDC7 kinase in normal and cancer cells: potential implications for cancer treatment

$456,860
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2023 · CA

Regulation of the nucleolar RNA exosome in cancer

$456,761
Mushui Dai · Oregon Health & Science University · R01 · FY2023 · CA

The Role of Akt in Cell Survival and Cell Growth

$456,744
Nissim Hay · University Of Illinois At Chicago · R01 · FY2020 · AG

The Role of Akt in Cell Survival and Cell Growth

$456,744
Nissim Hay · University Of Illinois At Chicago · R01 · FY2022 · AG

The Role of Akt in Cell Survival and Cell Growth

$456,744
Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · AG

The Role of Akt in Cell Survival and Cell Growth

$456,744
Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · AG

Integrin alpha6beta4 regulation of cancer epigenetics

$456,732
Kathleen L O'Connor · University Of Kentucky · R01 · FY2023 · CA

Integrin alpha6beta4 regulation of cancer epigenetics

$456,732
Kathleen L O'Connor · University Of Kentucky · R01 · FY2022 · CA

DIET, EXOGENOUS HORMONES, AND BREAST CANCER RISK

$456,730
Walter C. Willett · Brigham And Women'S Hospital · P01 · FY2009 · CA

An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.

$456,691
Christopher J Kemp · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Management of Mucositis with GM-CSF

$456,678
Marylin J Dodd · University Of California, San Francisco · R01 · FY2008 · CA

Molecular Targets for Cancer Detection and Treatment

$456,641
William George Nelson · Johns Hopkins University · T32 · FY2006 · CA

LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU

$456,618
Yale University · R01 · FY2000 · CA

CANCER RISK DETECTION BY MUTATIONAL LOAD DISTRIBUTION AN

$456,615
Yale University · U01 · FY2001 · CA